Table 3

The final testicular cancer QPIs v2.0 (21 June 2016)

Testicular quality performance indicatorsTarget (%)
1. Radiological staging—proportion of patients who undergo CT scanning, ideally contrast-enhanced CT, of the chest, abdomen and pelvis within 3 weeks of orchidectomy.95
2. Preoperative assessment—proportion of patients who undergo preoperative assessment of the testicle which includes (1) serum tumour markers (STM) and (2) testicular ultrasound.95
3. Primary orchidectomy—proportion of patients who undergo primary orchidectomy within 2 weeks of ultrasonographic diagnosis.
(Hospital of surgery)
95
4. Multidisciplinary team meeting—proportion of patients discussed at an MDT meeting to agree a definitive management plan after orchidectomy.95
5. Pathology reporting—proportion of patients undergoing orchidectomy where the pathology report contains full information (as per the Royal College of Pathologists (RCoP) data set).1990
6. Quality of adjuvant treatment—proportion of patients with stage I seminoma receiving adjuvant single-dose carboplatin within 8 weeks of orchidectomy.95
7. Serum tumour markers—proportion of patients with metastatic testicular cancer who undergo STMs 2 weeks before starting chemotherapy.98
8. Systemic therapy—proportion of patients with metastatic testicular cancer who undergo systemic anticancer therapy (SACT) within 3 weeks of an MDT decision to treat with SACT.95
9. CT scanning for surveillance patients—proportion of patients with ‘low-risk’ testicular non-seminomatous germ cell tumour (NSGCT) (or mixed) under surveillance who undergo at least three CT scans of the abdomen±chest and pelvis within 14 months of diagnosis. (Note: year 1 reporting)85
10a. 30-day mortality (orchidectomy)—proportion of patients who die within 30 days of treatment for testicular cancer.
(Hospital of surgery)
<5
10b. 30-day mortality (chemotherapy)—proportion of patients who die within 30 days of treatment for testicular cancer.<5
10c. 30-day mortality (radiotherapy)—proportion of patients who die within 30 days of treatment for testicular cancer.<5
11. Clinical trial—all patients should be considered for participation in available clinical trials, wherever eligible.>15
  • MDT, multidisciplinary team; QPI, quality performance indicator.